60 Einträge gefunden

1. First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

   1. Paschold, Lisa
   2. Stein, Alexander
   3. Thiele, Benjamin
   4. Tintelnot, Joseph
   5. Henkes, Svenja-Sibylla
   6. Coith, Cornelia
   7. Schultheiß, Christoph

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510

   1. Högner, Anica
   2. Al-Batran, Salah-Eddin
   3. Siveke, Jens T
   4. Lorenz, Mario
   5. Bartels, Prisca
   6. Breithaupt, Kirstin
   7. Malfertheiner, Peter

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

   1. Wen, Patrick Y
   2. Stein, Alexander
   3. van den Bent, Martin
   4. De Greve, Jacques
   5. Wick, Antje
   6. de Vos, Filip Y F L
   7. von Bubnoff, Nikolas

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Immunotherapy in Squamous Cell Cancer of the Esophagus

   1. Thuss-Patience, Peter
   2. Stein, Alexander

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

   1. Stein, Alexander
   2. Paschold, Lisa
   3. Tintelnot, Joseph
   4. Goekkurt, Eray
   5. Henkes, Svenja-Sibylla
   6. Simnica, Donjete
   7. Schultheiss, Christoph

   2022 - Forschungsinformationssystem des UKE
6. Long-Term Follow-Up Guidelines and Organization of Long-Term Follow-Up Care for Children and Young Adult Cancer Survivers

   1. Langer, T
   2. Beck, J D
   3. Stein, Alexander
   4. Bokemeyer, Carsten
   5. Gebauer, J

   2021 - Forschungsinformationssystem des UKE
7. Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

   1. Folprecht, Gunnar
   2. Trautmann, Karolin
   3. Stein, Alexander
   4. Huebner, Gerdt
   5. Stahl, Michael
   6. Kasper, Stefan
   7. Kretzschmar, Albrecht

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD

   1. Schmoll, Hans-Joachim
   2. Stein, Alexander
   3. Van Cutsem, Eric
   4. Price, Timothy
   5. Hofheinz, Ralf D
   6. Nordlinger, Bernard
   7. Daisne, Jean-François

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

   1. Stein, Alexander
   2. Simnica, Donjete
   3. Schultheiß, Christoph
   4. Scholz, Rebekka
   5. Tintelnot, Joseph
   6. Gökkurt, Eray
   7. von Wenserski, Lisa

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors

    1. Hilgendorf, Inken
    2. Bergelt, Corinna
    3. Bokemeyer, Carsten
    4. Kaatsch, Peter
    5. Seifart, Ulf
    6. Stein, Alexander
    7. Langer, Thorsten

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
11. Reply to P. Potemski and K. Bujko

    1. Schmoll, Hans-Joachim
    2. Mauer, Murielle E
    3. Marreaud, Sandrine
    4. Stein, Alexander

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
12. A Phase I dose-escalation study of third-line regorafenib with trifluridine/tipiracil in metastatic colorectal cancer

    1. Moehler, Markus
    2. Michel, Maurice
    3. Stein, Alexander
    4. Trojan, Joerg
    5. Marquardt, Jens
    6. Tintelnot, Joseph
    7. Waidmann, Oliver

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
13. Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF Inhibitors

    1. Simnica, Donjete
    2. Ittrich, Harald
    3. Bockemeyer, Carsten
    4. Stein, Alexander
    5. Binder, Mascha

    2020 - Forschungsinformationssystem des UKE
14. Current status of immunotherapy in gastrointestinal malignancies

    1. Lorenzen, Sylvie
    2. Lordick, Florian
    3. Loosen, Sven Heiko
    4. Tacke, Frank
    5. Trautwein, Christian
    6. Roderburg, Christoph
    7. Ettrich, Thomas J

    2020 - Forschungsinformationssystem des UKE
15. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family

    1. Niemeyer, Elisabeth
    2. Mofid, Hamid
    3. Zornig, Carsten
    4. Burandt, Eike-Christian
    5. Stein, Alexander
    6. Block, Andreas
    7. Volk, Alexander E

    2020 - Forschungsinformationssystem des UKE
16. Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work

    1. Gebauer, Judith
    2. Baust, Katja
    3. Bardi, Edit
    4. Grabow, Desiree
    5. Stein, Alexander
    6. van der Pal, Helena J
    7. Calaminus, Gabriele

    2020 - Forschungsinformationssystem des UKE
17. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays

    1. Rothkamm, Kai
    2. Christiansen, Sabrina
    3. Rieckmann, Thorsten
    4. Horn, Michael
    5. Frenzel, Thorsten
    6. Brinker, Alexandra
    7. Schumacher, Udo

    2020 - Forschungsinformationssystem des UKE
18. Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

    1. Cremolini, Chiara
    2. Antoniotti, Carlotta
    3. Stein, Alexander
    4. Bendell, Johanna
    5. Gruenberger, Thomas
    6. Rossini, Daniele
    7. Masi, Gianluca

    2020 - Forschungsinformationssystem des UKE
19. Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR):a phase 2, open-label, single-arm, multicentre basket trial

    1. Subbiah, Vivek
    2. Lassen, Ulrik
    3. Élez, Elena
    4. Italiano, Antoine
    5. Curigliano, Giuseppe
    6. Javle, Milind
    7. de Braud, Filippo

    2020 - Forschungsinformationssystem des UKE
20. Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19

    1. Malsy, Jakob
    2. Veletzky, Luzia
    3. Heide, Janna
    4. Hennigs, Annette
    5. Gil-Ibanez, Ines
    6. Stein, Alexander
    7. Lütgehetmann, Marc

    2020 - Forschungsinformationssystem des UKE - frei zugänglich